Literature DB >> 16935340

Choroideremia: variability of clinical and electrophysiological characteristics and first report of a negative electroretinogram.

Agnes B Renner1, Ulrich Kellner, Elke Cropp, Markus N Preising, Ian M MacDonald, José A J M van den Hurk, Frans P M Cremers, Michael H Foerster.   

Abstract

PURPOSE: To analyze the variability of clinical and electrophysiological characteristics in X-linked choroideremia and provide the first report of a negative electroretinogram in choroideremia.
DESIGN: Retrospective study. PARTICIPANTS: The records of 18 male patients with choroideremia and 8 female carriers were evaluated.
METHODS: The data were reviewed regarding visual acuity (VA), color vision, perimetry, fundus autofluorescence, and full-field electroretinography (according to standards of the International Society for Clinical Electrophysiology of Vision). MAIN OUTCOME MEASURES: Morphological and functional phenotype characteristics, fundus autofluorescence, electroretinography, and Rab escort protein 1 (REP-1) mutations.
RESULTS: Four unrelated families with choroideremia (9 affected males, 7 carriers) and 10 unrelated individuals (9 affected males, 1 carrier) were included. Mutational analysis, performed in 2 families and 3 individual males, revealed REP-1 mutations in all except 1 male. The age of the males ranged from 5.9 to 63.0 years (mean, 33.9), and VA ranged from hand movements to 1.0 (median, 0.7). Fundus autofluorescence (n = 7) showed defects in the retinal pigment epithelium in all males. Electroretinography (n = 13) was almost undetectable in 6 males and reduced in 6, indicating a rod-cone dystrophy. A further male showed a negative electroretinogram, with a b:a wave ratio of 0.5. Visual acuity of the 8 carriers (age, 4.8-56.8 years [mean, 24.0]) ranged from light perception to 1.2 (median, 1.0). Light perception was present in 1 carrier manifesting choroideremia with distinct chorioretinal atrophy. Pigmentary stippling, seen in the other carriers, was seen in fundus autofluorescence (n = 1) with a distinct speckled pattern. Electroretinograms were normal in 6 of 7 and reduced in the manifesting carrier. Defects in color vision and visual field were found in affected males and in the female carriers.
CONCLUSIONS: The phenotype of choroideremia presents with high variability. In addition to the previously reported findings, we observed a negative electroretinogram, indicating a postreceptoral retinal dysfunction, in 1 affected male; severe course of choroideremia with early blindness in 1 manifesting carrier; color vision deficits in the majority of affected males and carriers; and characteristic alterations in fundus autofluorescence.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16935340     DOI: 10.1016/j.ophtha.2006.05.045

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  23 in total

1.  Clinical utility gene card for: choroideremia.

Authors:  Mariya Moosajee; Simon C Ramsden; Graeme C M Black; Miguel C Seabra; Andrew R Webster
Journal:  Eur J Hum Genet       Date:  2013-08-21       Impact factor: 4.246

2.  Retinal dystrophy and subretinal drusenoid deposits in female choroideremia carriers.

Authors:  Vittoria Murro; Dario Pasquale Mucciolo; Ilaria Passerini; Simona Palchetti; Andrea Sodi; Gianni Virgili; Stanislao Rizzo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-07-27       Impact factor: 3.117

3.  Retinal pigment epithelium defects accelerate photoreceptor degeneration in cell type-specific knockout mouse models of choroideremia.

Authors:  Tanya Tolmachova; Silene T Wavre-Shapton; Alun R Barnard; Robert E MacLaren; Clare E Futter; Miguel C Seabra
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-05       Impact factor: 4.799

4.  Negative electroretinograms in the pediatric and adult population.

Authors:  Johnstone M Kim; John F Payne; Jiong Yan; Claire S Barnes
Journal:  Doc Ophthalmol       Date:  2012-01-13       Impact factor: 2.379

5.  Spectrum of Disease Severity and Phenotype in Choroideremia Carriers.

Authors:  Ruben Jauregui; Karen Sophia Park; Akemi J Tanaka; Ahra Cho; Maarjaliis Paavo; Jana Zernant; Jasmine H Francis; Rando Allikmets; Janet R Sparrow; Stephen H Tsang
Journal:  Am J Ophthalmol       Date:  2019-06-08       Impact factor: 5.258

6.  Natural History of the Central Structural Abnormalities in Choroideremia: A Prospective Cross-Sectional Study.

Authors:  Tomas S Aleman; Grace Han; Leona W Serrano; Nicole M Fuerst; Emily S Charlson; Denise J Pearson; Daniel C Chung; Anastasia Traband; Wei Pan; Gui-Shuang Ying; Jean Bennett; Albert M Maguire; Jessica I W Morgan
Journal:  Ophthalmology       Date:  2016-12-13       Impact factor: 12.079

7.  CHOROIDEREMIA: Retinal Degeneration With an Unmet Need.

Authors:  Mark E Pennesi; David G Birch; Jacque L Duncan; Jean Bennett; Aniz Girach
Journal:  Retina       Date:  2019-11       Impact factor: 4.256

8.  Retinal nerve fiber thickness measurements in choroideremia patients with spectral-domain optical coherence tomography.

Authors:  Mohamed A Genead; J Jason McAnany; Gerald A Fishman
Journal:  Ophthalmic Genet       Date:  2011-01-26       Impact factor: 1.803

9.  PHENOTYPING CHOROIDEREMIA AND ITS CARRIER STATE WITH MULTIMODAL IMAGING TECHNIQUES.

Authors:  Kevin K Ma; James Lin; Katherine Boudreault; Royce W S Chen; Stephen H Tsang
Journal:  Retin Cases Brief Rep       Date:  2017 Winter

10.  Clinical characteristics of a large choroideremia pedigree carrying a novel CHM mutation.

Authors:  Alex S Huang; Leo A Kim; Amani A Fawzi
Journal:  Arch Ophthalmol       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.